Endovascular Treatment in Ischemic Stroke Follow-up Evaluation (ETIS)

Hopital Foch

Status: Enrolling

Conditions: Stroke, Acute

Study type: Observational

Funder types: Other

Identifiers

NCT03776877

2017024F

Details and patient eligibility

About

Study like register with biomarkers samples for patient experiencing acute ischemic stroke, to assess clinical outcomes and different factors that may affect the clinical outcomes.

Enrollment: 4,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Age 18 and older (i.e., candidates must have had their 18th birthday)
• Neuroimaging demonstrates acute ischemic stroke with large vessel proximal with the use of neuro-thrombectomy devices intended to restore blood flow
• No upper or lower limits of the neurological severity at baseline (NIHSS).
• With or without intravenous thrombolysis
• Oral informed consent (patient and/or trustworthy person)

Non-inclusion Criteria:

• Pregnant or breast-feeding women
• Patient benefiting from a legal protection
• Non-membership of a national insurance scheme

Trial design

4,000 participants in 1 patient group

Arterial Ischemic Stroke (AIS)

Description:

All patients (prospective and retrospective) included will have to present an Arterial Ischemic Stroke (AIS) from a large cerebral vessel occlusion. The participation in the study will consist in: * Plasmatic collection at the time of AIS, for study of plasma biomarkers * Additional standardized blinded clinical evaluation at three months after the thrombectomy realized during a phone call, particularly via an assessment of the modified Rankin score.